Current and future applications of dried blood spots in viral disease management

Abstract

Almost five decades after their first application in diagnostics, dried blood spot (DBS) cards remain to be of key interest in many research areas and clinical applications. The advantages of sample stability during transport and storage, can now be combined with the high sensitivity of novel diagnostic techniques for the measurement and analysis of nucleic acids, proteins and small molecules which may overcome the limitations of the small samples sizes in DBS cards. Here we present a survey of the literature on the use of DBS cards for diagnosis, monitoring and epidemiological studies of virus infections other than HIV, including CMV, HBV, HCV, HAV, HEV, HTLV, EBV, HSV, measles-, rubella- and dengue-virus. The minimal invasiveness of sampling and the relative ease of handling and storing DBS cards is expected to offer additional opportunities to measure and analyze biomarkers of viral disease in resource poor settings or when limited amount of blood can be obtained. Large retrospective studies of virus infections in newborns using stored DBS cards have already been undertaken for screening of congenital infections. In addition, DBS cards have been used prospectively for prevalence studies, outbreak surveillance, mass screening for viral infections, follow-up of chronic infection and its treatment in resource-limited areas. We do not expect that current wet sampling techniques of plasma or serum will be replaced by DBS sampling but it allows extension of sampling in persons and settings that are currently difficult to access or that lack suitable storage facilities. In conclusion, DBS card sampling and storage will aid adequate outbreak management of existing and emerging viral diseases.

Introduction

Dried blood spot (DBS) cards have successfully been used in neonatal screening for almost half a century (Guthrie and Susi, 1963). Initially they were used for metabolic disease screening in neonates. With time and the development of new techniques, the disease range and possible applications of DBS have greatly been expanded. Traditionally, plasma and serum samples prepared from comparatively large quantities (typically 1–6 ml for adults) of whole blood after venipuncture are standard biological substrates for laboratory diagnosis, epidemiological surveys and therapy monitoring of viral infections. To prevent degradation, these samples normally need to be processed in the laboratory on the same day, and the products need to be kept frozen or refrigerated from isolation onwards. DBS samples are being tested as an alternative method of sampling for laboratory diagnosis, epidemiological studies and therapy monitoring of viral infections. DBS card samples can be prepared from a few drops of blood, typically 15–200 μl, obtained from a capillary blood stab, i.e. a finger prick (Turner and Holman, 1978). Thus, DBS cards also offer the opportunity to collect specimens from young children in whom venipuncture is difficult to perform and in whom sampling of even small blood volumes may be too demanding. Furthermore, taking a capillary blood stab requires little clinical training. Logistics and storage of DBS cards provides some important advantages over the traditionally used liquid forms of whole blood, serum and plasma (Parker and Cubitt, 1999). Viral RNA and DNA, antibodies or other proteins and antiviral drugs or their metabolites remain stable in DBS cards for relatively long periods when stored with desiccant in closed bags at ambient temperature, compared to wet plasma or serum stored under the same conditions. The cards are small and light and easily to transport safely.

A common protocol for all purposes comprises a minimum of 2 h drying of the blood spot, storage in plastic zip lock bags with desiccant. A maximum storage of 2 weeks at room temperature (RT) is recommended. Freezing at −20 °C is recommended when DBS cards are stored for more than 2 weeks (Mei et al., 2001, Therrell et al., 1996). Therefore, the cards can be sent by regular mail to a laboratory. Punched out disks from DBS cards normally contain the equivalent of 3.1–12.4 μl blood depending on the punch size (3–6 mm) (Corso et al., 2010). Increasing the number of disks is being used to enlarge the sample volume. A disadvantage of DBS samples compared with plasma or serum samples is the presence of erythrocytes and thus large amounts of hemoglobin that may interfere in PCR assays (Condorelli et al., 1994). A point that has received little attention in the literature is the safety. Some viruses remain infectious for long periods in dried splashes on surfaces and are likely to remain infectious in DBS (Rutula, 2008). This point has been addressed for dengue virus (Prado et al., 2005) and needs further attention for other viruses in future studies.

Recently, excellent reviews have been published on the use of DBS for diagnosis and therapy monitoring of HIV infection (Bertagnolio et al., 2010, Hamers et al., 2009, Johannessen et al., 2009). Here we present a review of the published literature on the use of DBS cards for diagnosis, monitoring and epidemiology of viral infections other than HIV. Our review summarizes data on the performance of DBS card assays compared to serum or plasma assays. We also provide data on the stability of various markers in DBS cards upon storage. In addition we will give a non-exhaustive overview of current applications of DBS cards. Finally, future perspectives on DBS cards use will be addressed.

For this review we identified relevant studies on DBS in PubMed (last search performed on the first of March in 2011). The search terms used were: dry or dried, in combination with blood or fluid or serum and spot. The selection criteria were limited by research on humans and the English language. The abstracts of 901 articles were studied for suitability. Studies on metabolic disease and HIV only were removed. Furthermore studies that only reported seroprevalence without analytical validation data were excluded. In addition, studies with analytical validation data that compared less than 10 positive samples were not taken into account. Finally, 44 studies fulfilled the criteria, comparing the performance of DBS card-based assays with the golden standard. These studies are included in the Table 1 with technical details on DBS sample recovery, signal detection and performance and stability of the DBS sample under various storage conditions.